drugset / Trial / NCT06953661

Ultrasound Guided Stellate Ganglion Block in Postural Tachycardia Syndrome

NCT06953661 ↗

Not yet recruiting 20 enrolled Stanford University
RandomizedParallel-groupTriple-blindTreatment

Summary

This single-center study aims to evaluate both immediate and long-term outcomes of stellate ganglion block (SGB) in a cohort of rigorously phenotyped patients with Postural Tachycardia Syndrome (POTS). By assessing the effects of SGB, this study seeks to determine its viability as an intervention for symptom control in POTS.

Timeline

Start
2025-10-13
Primary completion
2026-11
Completion
2026-11

Publications

Drugs

EvaluationDrugModalityDoseRoute
Background Ropivacaine Other / unclassified 0.5 % —
Background Ropivacaine Other / unclassified 10 ml —